Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-123,041
Closed -$6.59M 38
2022
Q4
$6.59M Sell
123,041
-96,043
-44% -$4.96M 0.62% 25
2022
Q3
$10.1M Sell
219,084
-416,350
-66% -$22.6M 0.95% 24
2022
Q2
$34.9M Sell
635,434
-635,829
-50% -$41M 3.05% 18
2022
Q1
$87.1M Buy
1,271,263
+23,193
+2% +$1.65M 6.1% 4
2021
Q4
$98.8M Buy
1,248,070
+577,552
+86% +$48.3M 6.24% 3
2021
Q3
$53M Buy
670,518
+236,121
+54% +$19M 3.51% 13
2021
Q2
$34.3M Buy
434,397
+239,750
+123% +$18.4M 2.24% 20
2021
Q1
$14.7M Buy
+194,647
New +$14.3M 1.09% 30

Other funds holding ENOV

Cooper Investors's ENOV Position: Q1 2023 in Review

Cooper Investors sold out of Enovis (ENOV) in Q1 2023, closing a stake of 123,041 shares — an estimated $6.59M sold.

Cooper Investors first reported a position in ENOV in Q1 2021 and held it in 8 quarters. The position peaked at $98.8M in Q4 2021. 249 funds tracked by Wall St. Rank hold ENOV as of Q1 2023.

  • Cooper Investors reported no remaining Enovis position as of Q1 2023 after selling out during the quarter.
  • Cooper Investors sold 123,041 Enovis shares in Q1 2023, an estimated $6.59M.
  • Cooper Investors first reported a position in Enovis in Q1 2021 and held it in 8 quarters.
  • Cooper Investors's Enovis position peaked at $98.8M in Q4 2021.
  • 249 funds tracked by Wall St. Rank held Enovis as of Q1 2023.

Based on Cooper Investors's 13F filing for Q1 2023, filed 10 Apr 2025.